tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APGE Stock Latest News

Mizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
RatingsMizuho Securities Recommends Buy for Apogee Therapeutics Due to Promising APG777 Efficacy in Th2 Inflammatory Diseases
6d ago
APGE
Apogee Therapeutics initiated with an Outperform at Mizuho
PremiumThe Fly
Apogee Therapeutics initiated with an Outperform at Mizuho
6d ago
APGE
Short Report: Fluence Energy short interest at record high
PremiumThe Fly
Short Report: Fluence Energy short interest at record high
7d ago
NNE
APGE
3 Best Stocks to Buy Now, 10/17/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/17/2025, According to Top Analysts
9d ago
FI
APGE
Apogee Therapeutics Raises $323.3 Million in Offering
PremiumCompany Announcements
Apogee Therapeutics Raises $323.3 Million in Offering
16d ago
8K
APGE
Buy Recommendation for Apogee Therapeutics: Promising Clinical Developments and Strategic Financial Moves
PremiumRatingsBuy Recommendation for Apogee Therapeutics: Promising Clinical Developments and Strategic Financial Moves
16d ago
APGE
Apogee Therapeutics price target lowered to $82 from $87 at BofA
Premium
The Fly
Apogee Therapeutics price target lowered to $82 from $87 at BofA
17d ago
APGE
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
Premium
The Fly
Apogee Therapeutics 6.95M share Spot Secondary priced at $41.00
17d ago
APGE
Closing Bell Movers: Costco nudges higher after September sales
PremiumThe Fly
Closing Bell Movers: Costco nudges higher after September sales
18d ago
AZZ
RGP
Apogee Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Apogee Therapeutics announces common stock offering, no amount given
18d ago
APGE
Apogee Therapeutics rises 14.5%
PremiumThe Fly
Apogee Therapeutics rises 14.5%
18d ago
APGE
Apogee Therapeutics initiated with an Outperform at RBC Capital
PremiumThe Fly
Apogee Therapeutics initiated with an Outperform at RBC Capital
1M ago
APGE
Wall Street Sees Massive Growth Potential in These 3 Russell 2000 Stocks
PremiumMarket NewsWall Street Sees Massive Growth Potential in These 3 Russell 2000 Stocks
2M ago
APGE
BEAM
3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 8/28/2025, According to Top Analysts
2M ago
NXE
APGE
Apogee Therapeutics price target raised to $87 from $78 at BofA
Premium
The Fly
Apogee Therapeutics price target raised to $87 from $78 at BofA
2M ago
APGE
Promising Prospects for Apogee Therapeutics: Buy Rating Backed by Strong Trial Results and Financial Health
PremiumRatings
Promising Prospects for Apogee Therapeutics: Buy Rating Backed by Strong Trial Results and Financial Health
3M ago
APGE
Apogee Therapeutics Faces Supply Chain Risks Amid Geopolitical Tensions and Regulatory Challenges
PremiumCompany Announcements
Apogee Therapeutics Faces Supply Chain Risks Amid Geopolitical Tensions and Regulatory Challenges
3M ago
APGE
Apogee Therapeutics Reports Promising Trial Results and Strong Cash Position
PremiumCompany Announcements
Apogee Therapeutics Reports Promising Trial Results and Strong Cash Position
3M ago
APGE
Apogee Therapeutics reports Q2 net loss ($66.1M) vs ($33.816M) last year
PremiumThe Fly
Apogee Therapeutics reports Q2 net loss ($66.1M) vs ($33.816M) last year
3M ago
APGE
Apogee Therapeutics expects cash to fund operations into Q1 of 2028
PremiumThe FlyApogee Therapeutics expects cash to fund operations into Q1 of 2028
3M ago
APGE
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
Premium
Market News
Analysts Spot 3 Strong Buy Russell 2000 Stocks with 100% Upside
3M ago
APGE
BEAM
Apogee Therapeutics price target raised to $115 from $100 at BTIG
Premium
The Fly
Apogee Therapeutics price target raised to $115 from $100 at BTIG
4M ago
APGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >